Enzyme Immunoassay Detection of Antibodies in North American Blastomycosis: Comparison of Three Blastomyces dermatitidis Antigens/Enzymimmunoassay zum Antikörpernachweis bei Nordamerikanischer Blastomykose: Vergleich dreier Blastomyces dermatitidis‐Antigene
Enzyme Immunoassay Detection of Antibodies in North American Blastomycosis: Comparison of Three Blastomyces dermatitidis Antigens/Enzymimmunoassay zum Antikörpernachweis bei Nordamerikanischer Blastomykose: Vergleich dreier Blastomyces dermatitidis‐Antigene
复制标题
北美芽生菌病抗体的酶免疫分析检测:三种皮炎芽生菌抗原的比较/酶免疫分析 zum Antikörpernachweis bei Nordamerikanischer Blastomykose: Vergleich dreier Blastomyces dermatitidis-Antigene
DOI:
10.1111/j.1439-0507.1988.tb03650.x
复制
发表时间:
1988
期刊:
影响因子:
4.9
通讯作者:
G. M. Scalarone
中科院分区:
文献类型:
--
作者:
J. Wheeler;R. D. Owens;G. M. Scalarone
Summary: Three Blastomyces dermatitidis commercial immunodiffusion antigens, Meridian Diagnostics, Nolan/Scott Laboratories and American Microsan, were utilized in an enzyme immunoassay (ELISA) for the detection of antibodies in blastomycosis. Thirty two serum specimens from patients with blastomycosis were assayed by the indirect ELISA using the alkaline phosphatase enzyme system. Greater reactivity, based on the ELISA index value, was evidenced with the Meridian Diagnostics antigen; the other two antigens exhibited lower but comparable reactivity. Specificity was determined by performing cross‐reactivity assays on sera from patients with histoplasmosis or on specimens from individuals that More Histoplasma capsulatum skin test positive. Comparable specificity results were obtained with all three antigens.